MYLK and neoplasm: A recent study demonstrated that PI3KCG stimulates MLCK210, a high molecular weight type of myosin light chain kinase, which activates Rap1 GTP loading and modifies the conformation of integrin α4β1, which promotes tumor inflammation and progression (Schmid et al., 2022).